Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma.
Baird JR, Bell RB, Troesch V, Friedman D, Bambina S, Kramer G, Blair TC, Medler T, Wu Y, Sun Z, de Gruijl TD, van de Ven R, Leidner RS, Crittenden MR, Gough MJ. Baird JR, et al. Among authors: van de ven r, de gruijl td. Cancer Res. 2018 Nov 1;78(21):6308-6319. doi: 10.1158/0008-5472.CAN-18-1652. Epub 2018 Sep 17. Cancer Res. 2018. PMID: 30224374
NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models.
Gruijs M, Ganzevles SH, Stigter-van Walsum M, van der Mast R, van Ostaijen-Ten Dam MM, Tuk CW, Schilham MW, Leemans CR, Brakenhoff RH, van Egmond M, van de Ven R, Bakema JE. Gruijs M, et al. Among authors: van der mast r, van de ven r, van ostaijen ten dam mm, van egmond m. Int J Mol Sci. 2021 Oct 14;22(20):11057. doi: 10.3390/ijms222011057. Int J Mol Sci. 2021. PMID: 34681717 Free PMC article.
Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy.
van Duijvenvoorde M, Derks S, Bahce I, Leemans CR, van de Ven R, Fransen MF. van Duijvenvoorde M, et al. Among authors: van de ven r. Clin Transl Immunology. 2022 Jan 10;11(1):e1363. doi: 10.1002/cti2.1363. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35035956 Free PMC article. Review.
Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites.
Muijlwijk T, Nijenhuis DNLM, Ganzevles SH, Brink A, Ke C, Fass JN, Rajamanickam V, Leemans CR, Koguchi Y, Fox BA, Poell JB, Brakenhoff RH, van de Ven R. Muijlwijk T, et al. Among authors: van de ven r. J Immunother Cancer. 2024 Jan 11;12(1):e007573. doi: 10.1136/jitc-2023-007573. J Immunother Cancer. 2024. PMID: 38212122 Free PMC article.
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer.
Wondergem NE, Miedema IHC, van de Ven R, Zwezerijnen GJC, de Graaf P, Karagozoglu KH, Hendrickx JJ, Eerenstein SEJ, Bun RJ, Mulder DC, Voortman J, Boellaard R, Windhorst AD, Hagers JP, Peferoen LAN, de Gruijl TD, Bloemena E, Brakenhoff RH, Leemans CR, Menke-van der Houven van Oordt CW. Wondergem NE, et al. Among authors: van de ven r. J Immunother Cancer. 2024 Jul 22;12(7):e009278. doi: 10.1136/jitc-2024-009278. J Immunother Cancer. 2024. PMID: 39038919 Free PMC article.
Immune cell topography of head and neck cancer.
Muijlwijk T, Nijenhuis DNLM, Ganzevles SH, Ekhlas F, Ballesteros-Merino C, Peferoen LAN, Bloemena E, Fox BA, Poell JB, Leemans CR, Brakenhoff RH, van de Ven R. Muijlwijk T, et al. Among authors: van de ven r. J Immunother Cancer. 2024 Jul 24;12(7):e009550. doi: 10.1136/jitc-2024-009550. J Immunother Cancer. 2024. PMID: 39053947 Free PMC article.
Secretome and immune cell attraction analysis of head and neck cancers.
Muijlwijk T, Wondergem NE, Ekhlas F, Remkes N, Nijenhuis DNLM, Fritz L, Ganzevles SH, Miedema IHC, Leemans CR, Poell JB, Brakenhoff RH, van de Ven R. Muijlwijk T, et al. Among authors: van de ven r. Cancer Immunol Immunother. 2024 Sep 9;73(11):229. doi: 10.1007/s00262-024-03809-z. Cancer Immunol Immunother. 2024. PMID: 39249543 Free PMC article.
Hallmarks of a genomically distinct subclass of head and neck cancer.
Muijlwijk T, Nauta IH, van der Lee A, Grünewald KJT, Brink A, Ganzevles SH, Baatenburg de Jong RJ, Atanesyan L, Savola S, van de Wiel MA, Peferoen LAN, Bloemena E, van de Ven R, Leemans CR, Poell JB, Brakenhoff RH. Muijlwijk T, et al. Among authors: van de ven r. Nat Commun. 2024 Oct 20;15(1):9060. doi: 10.1038/s41467-024-53390-3. Nat Commun. 2024. PMID: 39428388 Free PMC article.
149 results